564 related articles for article (PubMed ID: 23873857)
1. Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: a comparison with surgical cut-down and closure.
Nakamura M; Chakravarty T; Jilaihawi H; Doctor N; Dohad S; Fontana G; Cheng W; Makkar RR
Catheter Cardiovasc Interv; 2014 Aug; 84(2):293-300. PubMed ID: 23873857
[TBL] [Abstract][Full Text] [Related]
2. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.
Griese DP; Reents W; Diegeler A; Kerber S; Babin-Ebell J
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E734-41. PubMed ID: 23765732
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation.
Genereux P; Kodali S; Leon MB; Smith CR; Ben-Gal Y; Kirtane AJ; Daneault B; Reiss GR; Moses JW; Williams MR
JACC Cardiovasc Interv; 2011 Aug; 4(8):861-7. PubMed ID: 21851899
[TBL] [Abstract][Full Text] [Related]
4. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of surgical cutdown versus percutaneous access in transfemoral TAVR.
Holper EM; Kim RJ; Mack M; Brown D; Brinkman W; Herbert M; Stewart W; Vance K; Bowers B; Dewey T
Catheter Cardiovasc Interv; 2014 Feb; 83(3):457-64. PubMed ID: 23703878
[TBL] [Abstract][Full Text] [Related]
6. Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
Zaman S; Gooley R; Cheng V; McCormick L; Meredith IT
Catheter Cardiovasc Interv; 2016 Aug; 88(2):276-84. PubMed ID: 27107395
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
[TBL] [Abstract][Full Text] [Related]
8. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
Saleh N; De Palma R; Settergren M; Rück A
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
[TBL] [Abstract][Full Text] [Related]
9. Suture-mediated arterial access site closure after transfemoral aortic valve implantation.
Kahlert P; Al-Rashid F; Plicht B; Konorza T; Neumann T; Thielmann M; Wendt D; Erbel R; Eggebrecht H
Catheter Cardiovasc Interv; 2013 Feb; 81(2):E139-50. PubMed ID: 22553193
[TBL] [Abstract][Full Text] [Related]
10. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
11. Expandable sheath for transfemoral transcatheter aortic valve replacement: procedural outcomes and complications.
Borz B; Durand E; Tron C; Godin M; Canville A; Hauville C; Cribier A; Eltchaninoff H
Catheter Cardiovasc Interv; 2014 May; 83(6):E227-32. PubMed ID: 24403004
[TBL] [Abstract][Full Text] [Related]
12. Successful use of a left ventricular apical access and closure device for second-generation transapical aortic valve implantation.
Conradi L; Seiffert M; Shimamura K; Schirmer J; Blankenberg S; Reichenspurner H; Diemert P; Treede H
Thorac Cardiovasc Surg; 2014 Sep; 62(6):498-502. PubMed ID: 24911901
[TBL] [Abstract][Full Text] [Related]
13. Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: "the Hamburg Sankt Georg approach".
Schäfer U; Ho Y; Frerker C; Schewel D; Sanchez-Quintana D; Schofer J; Bijuklic K; Meincke F; Thielsen T; Kreidel F; Kuck KH
JACC Cardiovasc Interv; 2012 May; 5(5):477-486. PubMed ID: 22625184
[TBL] [Abstract][Full Text] [Related]
14. Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI?
Spitzer SG; Wilbring M; Alexiou K; Stumpf J; Kappert U; Matschke K
Catheter Cardiovasc Interv; 2016 Aug; 88(2):E52-8. PubMed ID: 26708225
[TBL] [Abstract][Full Text] [Related]
15. Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - a contemporary experience.
Cohen MG; Singh V; Martinez CA; O'Neill BP; Alfonso CE; Martinezclark PO; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Nov; 82(6):987-93. PubMed ID: 23729031
[TBL] [Abstract][Full Text] [Related]
16. Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the Prostar system in 118 cases.
Cockburn J; de Belder A; Brooks M; Hutchinson N; Hill A; Trivedi U; Hildick-Smith D
Catheter Cardiovasc Interv; 2012 Jan; 79(1):143-9. PubMed ID: 21538787
[TBL] [Abstract][Full Text] [Related]
17. Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion.
Binder RK; Barbanti M; Ye J; Toggweiler S; Tan J; Freeman M; Cheung A; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2014 May; 83(6):E221-6. PubMed ID: 24402965
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement.
Lardizabal JA; Macon CJ; O'Neill BP; Desai H; Singh V; Martinez CA; Alfonso CE; Cohen MG; Heldman AW; O'Neill WW; Williams DB
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1226-30. PubMed ID: 25511236
[TBL] [Abstract][Full Text] [Related]
19. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the femoral and radial crossover techniques for vascular access management in transcatheter aortic valve implantation: the Milan experience.
Curran H; Chieffo A; Buchanan GL; Bernelli C; Montorfano M; Maisano F; Latib A; Maccagni D; Carlino M; Figini F; Cioni M; La Canna G; Covello RD; Franco A; Gerli C; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2014 Jan; 83(1):156-61. PubMed ID: 23475626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
